Why are surgical and medical robots such high-value targets?
Surgical and medical robots combine every property attackers look for: high capital value, low tolerance for downtime, dense network connectivity, and a direct line to patient safety. A single surgical system can cost seven figures and generate revenue on a tight schedule, which makes a hospital acutely willing to pay to restore it. That is the textbook profile of a ransomware target, and healthcare has been the most-attacked sector for ransomware for several years running.
The exposure is not hypothetical. Medical robots and their consoles run on general-purpose operating systems, connect to hospital networks for imaging, logging, and remote service, and often carry firmware that is patched slowly because any change must be revalidated. Regulators have flagged the pattern directly: the FDA has issued safety communications about cybersecurity vulnerabilities in connected medical devices, and connected-device vulnerabilities routinely appear in coordinated disclosure. A compromised console does not have to move a surgical arm to cause harm, disabling it mid-schedule, corrupting its logs, or holding its data hostage is damaging enough.
What makes robots different from a compromised records server is the physical consequence class. The concern that keeps clinical engineering teams up at night is not only data theft but assurance: can the team prove the robot in front of a patient is running the firmware it should, carries the identity it claims, and has executed only authorized commands? Today that assurance usually rests on trust in the vendor and an editable local log. RankShield exists to replace that trust with verifiable evidence, an attested identity, attested firmware, and a tamper-evident record, so a high-value target stops being an unaccountable one. This is the same layer described on healthcare robot security for the whole hospital fleet.
How do you secure a surgical robot without adding procedural risk?
You keep every security check off the safety-critical control loop. RankShield attestation verifies identity, firmware, and action authorization at points where a delay or a denial cannot destabilize a live procedure, never inside the real-time control timing that moves an instrument. Attestation can refuse to start a robot, quarantine a bad build, or deny an out-of-policy command before a case, but it is architected so it can never inject latency into the tightest safety-rated control paths.
Concretely, the highest-consequence verification happens before the procedure and at bounded decision points, not on every control-loop tick. Firmware and policy are attested during startup and before a case begins; per-robot identity is verified when the system authenticates; and the action provenance record is written asynchronously so producing the receipt never gates motion. Where a pre-actuation authorization gate applies, it targets discrete high-consequence commands, and it is deployed only in modes and on interfaces where a deny cannot compromise clinical safety, for example refusing a remote-service instruction or a firmware push, not arbitrating a surgeon's real-time instrument input.
This ordering is the entire design philosophy for clinical robots. The security layer fails toward safety: if attestation is unavailable, the device's own safety systems remain in full control, because RankShield sits alongside them rather than in their path. That is why the honest claim here is narrow and defensible, RankShield reduces the attack surface and produces verifiable evidence, and it does so without ever becoming a new dependency inside the loop that keeps a patient safe.
How does this align with FDA cybersecurity guidance?
RankShield maps directly to the FDA's premarket and postmarket cybersecurity expectations for medical devices, secure identity, verifiable software integrity, and evidence you can maintain across a device's life. The FDA's premarket guidance asks manufacturers to design in security, document a secure architecture, and support software integrity and authenticity; its postmarket guidance and the device-cybersecurity provisions added to the FD&C Act (section 524B for cyber devices) ask for ongoing monitoring, patching, and a software bill of materials. Attestation is a natural fit for those obligations because it turns "we designed it securely" into evidence a manufacturer or hospital can actually produce on demand.
On the premarket side, per-robot hardware-rooted identity and RATS firmware attestation give a manufacturer a concrete mechanism for software authenticity and integrity: the device can prove its running build matches a signed reference, which is exactly the assurance premarket reviewers look for. On the postmarket side, tamper-evident provenance and continuous appraisal support the monitoring and demonstrable-integrity expectations, you can show, per device and over time, that the firmware in service is the approved one and that unauthorized changes are detected and contained.
The honest framing matters: RankShield is a security and evidence layer, not a regulatory clearance and not a substitute for a manufacturer's own quality and safety processes. It does not make a device compliant by itself, and nothing here is legal or regulatory advice. What it does is give the people responsible for that compliance verifiable artifacts, attested identity, attested firmware, and provenance receipts, that align with what FDA guidance asks them to establish and maintain. The broader mapping to standards and regulators lives on the robot cybersecurity standards hub.
How does per-procedure provenance help with liability?
A per-procedure attested provenance receipt is verifiable evidence of exactly what the robot's software state and command history were during a case, which is both patient-safety assurance and malpractice-defense material. When an adverse event is reviewed, the central questions are factual: was the device running approved firmware, was it the authentic device, and did it execute only authorized commands? A conventional local log cannot answer those questions credibly because whoever controls the device can edit it. A transparency-log receipt can.
RankShield seals each procedure's relevant events, the attested firmware version in effect, the verified device identity, and the authorization verdicts for high-consequence commands, as leaves in an append-only Merkle transparency log built on the RFC 6962 standard. Each receipt carries an inclusion proof, mathematical evidence that the record exists unchanged at a fixed position in the log, which an independent reviewer can verify without trusting the hospital or the manufacturer. That converts "our records show" into "here is cryptographic proof."
For the clinical and legal picture, that distinction is decisive. If a robot performed within policy on approved firmware, the provenance receipt is affirmative defense evidence that the device operated as intended. If something genuinely went wrong, the same record supports honest reconstruction rather than disputes over an editable log. Insurers increasingly want this kind of verifiable posture rather than a self-attested checklist, which is why the healthcare deployment treats provenance as a first-class deliverable. RankShield produces the evidence; it does not adjudicate liability, and it is not a substitute for legal counsel.
Can you verify firmware before a procedure begins?
Yes, firmware verification before a procedure is the core clinical use case, and it happens before the robot is trusted for a case rather than during it. Acting as an IETF RATS verifier, RankShield asks the robot (the attester) to present signed evidence about its running firmware and policy, conveyed as an Entity Attestation Token and rooted in the device's hardware. The platform appraises that evidence against a known-good, signed reference. If the build matches, the robot is cleared; if it has been tampered with, silently downgraded to a vulnerable version, or drifted from policy, appraisal fails and the device is quarantined from privileged operation before the case starts.
Placing this check pre-procedure is deliberate. It gives clinical engineering a hard, verifiable gate at the safest possible moment, when refusing to proceed costs a schedule slot, not a patient's safety mid-operation. It also directly answers the software-integrity question that FDA guidance and hospital security teams both ask: not "do we think the firmware is fine," but "can the device prove it is running the approved build right now." The full appraisal flow, hardware roots of trust (TPM, DICE, secure elements), and downgrade detection are described on RATS firmware attestation for robots.
The scope stays honest. Attestation proves that the firmware presenting evidence matches a signed reference; it is not a guarantee that certified software is free of latent defects, and it verifies the device's self-reported state through a hardware root of trust rather than certifying every sensor reading as ground truth. What it removes is the large, exploited class of attacks that depend on running altered or downgraded code undetected, and it removes them before the procedure, where that assurance matters most.
How does it integrate with hospital OT and clinical systems?
RankShield deploys as an overlay across hospital operational technology, it issues identities, attests firmware, and records provenance without replacing the medical device's own control software or its safety systems. Hospitals run a heterogeneous OT estate: surgical consoles, delivery and disinfection robots, imaging, and the segmented clinical networks that connect them. RankShield adds a uniform identity, attestation, and provenance plane across that estate rather than asking each vendor's stack to change, which is what makes it deployable in a mixed-vendor hospital rather than on a single robot model.
In practice, integration issues each robot a hardware-rooted attested identity, attests firmware at startup and before procedures, and streams tamper-evident receipts to the transparency log, while respecting the network segmentation and change-control that clinical environments require. Attestation verdicts can gate the operations a security team actually wants gated, such as remote-service access or a firmware push, and quarantine a device that fails appraisal, without touching the safety-critical control path. A bounded pilot typically covers identity, pre-procedure firmware attestation, and provenance on a defined set of robots within weeks, sequenced around clinical schedules.
Honest scope: RankShield does not replace a medical robot's functional-safety systems, its regulatory clearance, or its e-stop; it is not "unhackable," and it is not medical or legal advice. It cannot certify a spoofed sensor reading as fake, it can sign a reading's provenance, not verify the physical world. What it adds is the missing verifiable layer: proof of identity, proof of firmware, and proof of what happened, delivered so it strengthens patient safety and accountability instead of competing with the systems that protect the patient. To scope a pilot, request early access.
Frequently asked questions
Does RankShield touch the real-time control loop of a surgical robot?
No. Every security check runs off the safety-critical control timing. Firmware and identity are verified before a procedure and at bounded decision points, and provenance is recorded asynchronously, so attestation can refuse or quarantine a build but never injects latency into the loop that moves an instrument. If attestation is unavailable, the device's own safety systems remain in full control.
Is this a substitute for the medical device's own safety systems or FDA clearance?
No. RankShield is a security and evidence layer. It does not replace a device's functional-safety systems, its e-stop, or its regulatory clearance, and it does not by itself make a device compliant. It produces verifiable artifacts, attested identity, attested firmware, and provenance receipts, that align with FDA premarket and postmarket cybersecurity guidance. Nothing here is medical or legal advice.
How does per-procedure provenance help in a malpractice or adverse-event review?
It provides tamper-evident proof of the firmware version, verified device identity, and authorization verdicts in effect during the case, sealed in an RFC 6962 transparency log with an inclusion proof an independent reviewer can verify. That converts an editable local log into cryptographic evidence the robot operated on approved firmware within policy, or supports honest reconstruction if something went wrong.
Can you really verify firmware before a procedure without slowing the schedule?
Yes. Pre-procedure attestation uses the IETF RATS model: the robot presents signed EAT evidence rooted in hardware, and RankShield appraises it against a signed reference in the seconds around startup or case setup. A pass clears the device; a tampered or downgraded build fails appraisal and is quarantined before the case, when refusing to proceed costs a schedule slot rather than patient safety.
How does it fit a mixed-vendor hospital OT environment?
RankShield deploys as an overlay across the OT estate, issuing a uniform identity, attestation, and provenance plane without changing each vendor's control software. It respects existing network segmentation and change-control, gates operations like remote service or firmware pushes, and can run a bounded pilot on a defined set of robots within weeks, sequenced around clinical schedules.